Afinum and SHS Capital have sold their stakes in Switzerland-based diagnostic and therapeutic antibodies specialist Evitria to Sweden-based Atlas Antibodies in a deal that values Evitria at more than EUR 200m.
Afinum and SHS Capital have sold their stakes in Switzerland-based diagnostic and therapeutic antibodies specialist Evitria to Sweden-based Atlas Antibodies in a deal that values Evitria at more than EUR 200m.